Literature DB >> 8192523

Efficacy of ivermectin treatment of Loa loa filariasis patients without microfilaraemias.

P Hovette1, J M Debonne, J E Touze, P Gaxotte, P Imbert, L Fourcade, R Laroche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8192523     DOI： 10.1080/00034983.1994.11812842

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


× No keyword cloud information.
  3 in total

1.  Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo.

Authors:  Jean-Claude Makenga Bof; Daniel Muteba; Paul Mansiangi; Félicien Ilunga-Ilunga; Yves Coppieters
Journal:  BMC Pharmacol Toxicol       Date:  2019-08-16       Impact factor: 2.483

2.  Collateral Impact of Community-Directed Treatment with Ivermectin (CDTI) for Onchocerciasis on Parasitological Indicators of Loa loa Infection.

Authors:  Hugues C Nana-Djeunga; Cédric G Lenou-Nanga; Cyrille Donfo-Azafack; Linda Djune-Yemeli; Floribert Fossuo-Thotchum; André Domche; Arsel V Litchou-Tchuinang; Jean Bopda; Stève Mbickmen-Tchana; Thérèse Nkoa; Véronique Penlap; Francine Ntoumi; Joseph Kamgno
Journal:  Pathogens       Date:  2020-12-12

3.  Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.

Authors:  Samuel Wanji; Winston Patrick Chounna Ndongmo; Fanny Fri Fombad; Jonas Arnaud Kengne-Ouafo; Abdel Jelil Njouendou; Yolande Flore Longang Tchounkeu; Benjamin Koudou; Moses Bockarie; Grace Fobi; Jean Baptiste Roungou; Peter A Enyong
Journal:  PLoS Negl Trop Dis       Date:  2018-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.